Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.38B |
| 2 |
Blackrock
BLK
|
+$2.31B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.87B |
| 4 |
Microsoft
MSFT
|
+$1.6B |
| 5 |
Diamondback Energy
FANG
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.19B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.04B |
| 3 |
JPMorgan Chase
JPM
|
+$1.99B |
| 4 |
Morgan Stanley
MS
|
+$1.94B |
| 5 |
Caterpillar
CAT
|
+$1.9B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.13% |
| 2 | Healthcare | 17.38% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.42% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
1526
Jade Biosciences
JBIO
$1.34B
| $1.81M | ﹤0.01% |
129,166
+26,546
| +26% | +$384K |
|
1527
CAE Inc. Common Shares
CAE
$8.74B
| $1.81M | ﹤0.01% |
69,697
+1,805
| +3% | +$54.6K |
|
|
MAZE
1528
Maze Therapeutics
MAZE
$1.59B
| $1.81M | ﹤0.01% |
60,587
-618
| -1% | -$27.3K |
|
1529
ArriVent BioPharma
AVBP
$1.44B
| $1.8M | ﹤0.01% |
78,213
-4,065
| -5% | -$91.8K |
|
1530
UroGen Pharma
URGN
$2.29B
| $1.8M | ﹤0.01% |
100,215
-25,819
| -20% | -$518K |
|
1531
Theravance Biopharma
TBPH
$877M
| $1.78M | ﹤0.01% |
109,700
-13,265
| -11% | -$235K |
|
1532
Skyworks Solutions
SWKS
$10.6B
| $1.77M | ﹤0.01% |
33,040
+7,938
| +32% | +$462K |
|
1533
First Community Corp
FCCO
$322M
| $1.76M | ﹤0.01% |
60,238
-1,317
| -2% | -$38.6K |
|
1534
Pulse Biosciences
PLSE
$3.02B
| $1.75M | ﹤0.01% |
+81,252
| New | +$1.5M |
|
1535
Cincinnati Financial
CINF
$27.1B
| $1.74M | ﹤0.01% |
+11,042
| New | +$1.8M |
|
1536
Inhibrx
INBX
$1.3B
| $1.73M | ﹤0.01% |
25,785
-2,608
| -9% | -$193K |
|
1537
Eton Pharmaceutcials
ETON
$1.22B
| $1.73M | ﹤0.01% |
70,124
-11,077
| -14% | -$194K |
|
1538
Crocs
CROX
$6.55B
| $1.69M | ﹤0.01% |
+20,351
| New | +$1.74M |
|
1539
iShares MSCI Emerging Markets ETF
EEM
$30B
| $1.68M | ﹤0.01% |
29,645
+19,048
| +180% | +$1.12M |
|
1540
FMC
FMC
$1.33B
| $1.67M | ﹤0.01% |
96,991
-6,957
| -7% | -$104K |
|
1541
Bowman Consulting
BWMN
$477M
| $1.67M | ﹤0.01% |
+58,600
| New | +$1.91M |
|
1542
CRISPR Therapeutics
CRSP
$5.17B
| $1.66M | ﹤0.01% |
34,869
+797
| +2% | +$42K |
|
1543
TransDigm Group
TDG
$67.7B
| $1.65M | ﹤0.01% |
1,427
+322
| +29% | +$422K |
|
1544
Las Vegas Sands
LVS
$29.6B
| $1.64M | ﹤0.01% |
30,347
+4,670
| +18% | +$266K |
|
1545
Ironwood Pharmaceuticals
IRWD
$714M
| $1.59M | ﹤0.01% |
453,515
-50,427
| -10% | -$207K |
|
1546
Ligand Pharmaceuticals
LGND
$6.36B
| $1.58M | ﹤0.01% |
7,906
-520
| -6% | -$103K |
|
1547
Fortive
FTV
$18.6B
| $1.58M | ﹤0.01% |
28,527
+4,724
| +20% | +$265K |
|
1548
Brink's
BCO
$4.62B
| $1.56M | ﹤0.01% |
15,012
-7,625
| -34% | -$914K |
|
1549
Envista
NVST
$4.52B
| $1.55M | ﹤0.01% |
61,055
-51,004
| -46% | -$1.32M |
|
1550
iShares MSCI UAE ETF
UAE
$322M
| $1.55M | ﹤0.01% |
83,027
-7,019
| -8% | -$140K |
|
Similar funds
Wellington Management Group's Q1 2026 Portfolio in Review
As of Q1 2026, Wellington Management Group held 2,039 positions worth $535B, down 6.2% from $571B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Wellington Management Group's Q1 2026 filing shows 153 new, 707 increased, 906 reduced and 170 closed positions. Its largest new stake was Sunbelt Rentals Holdings: 11,221,373 shares worth $703M. The largest sale was Apple, an estimated $3.19B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Wellington Management Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 11,221,373 shares worth $703M.
- Wellington Management Group added most to AstraZeneca in Q1 2026, an estimated $2.38B increase.
- Wellington Management Group's biggest Q1 2026 reduction was Apple, cutting an estimated $3.19B.
- Wellington Management Group fully exited Synovus in Q1 2026, selling an estimated $341M.
- Wellington Management Group's ten largest holdings make up 26% of its $535B portfolio in Q1 2026.
- Wellington Management Group opened 153 new positions and closed 170 in Q1 2026.
- Wellington Management Group's portfolio value fell 6.2% quarter-over-quarter to $535B.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.